Q
QUOIN PHARMACEUTICALS LTD DRC
NASDAQ: QNRX (Quoin Pharmaceuticals, Ltd.)
最近更新时间: 13小时之前7.06
0.05 (0.71%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Quoin Pharmaceuticals, Ltd. | 混合的 | 混合的 |
AIStockmoo 评分
0.5
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 1.5 |
| 技术振荡指标 | 2.0 |
| 平均 | 0.50 |
|
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 内部持股比例 | 7.08% |
| 机构持股比例 | 7.24% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Dauntless Investment Group, Llc | 30 Jun 2026 | 214,987 |
| Summittx Capital, L.P. | 30 Jun 2026 | 100,300 |
| Aberdeen Group Plc | 30 Jun 2026 | 75,000 |
| Birchview Capital, Lp | 30 Jun 2026 | 20,000 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合